Axonal sprouting in hippocampus of cats infected with feline immunodeficiency virus (FIV)

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue 1, 1998, Pages 1-8

  Mitchell, Thomas W ^a   Buckmaster, Paul S ^a,b   Hoover, Edward A ^a   Whalen, L Ray ^a   Dudek, F Edward ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal model; Dentate gyrus; Hilus; Lentivirus; Mossy fibers; Sprouting; Timm's stain

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DENTATE GYRUS; FELINE IMMUNODEFICIENCY VIRUS; GRANULE CELL; HIPPOCAMPUS; NERVE SPROUTING; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; TEMPORAL LOBE EPILEPSY;

ANIMALIA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; HIPPOCAMPUS HIPPOCAMPUS; LENTIVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0031983838     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199801010-00001     Document Type: Article

References (75)

1. Pedersen NC, Ho EW, Brown ML, Yamamoto JK. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 1987;235:790-3.
2. Yamamoto JK, Hansen H, Ho EW, et al. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc 1989;194:213-20.
3. Sparger EE, Luciw PA, Elder JH, Yamamoto JK, Lowenstine LJ, Pedersen NC. Feline immunodeficiency virus is a lentivirus associated with an AIDS-like disease in cats. AIDS 1989;3:543-9.
4. Boche D, Hurtrel M, Gray F, Claessens-Maire M-A, Ganière J-P, Montagnier L, Hurtrel B. Virus load and neuropathology in the FIV model. J Neurovirol 1996;2:377-87.
5. Hurtrel M, Ganière J-P, Guelfi J-F, et al. Comparison of early and late feline immunodeficiency virus encephalopathies. AIDS 1992; 6:399-406.
6. Dow SW, Poss ML, Hoover EA. Feline immunodeficiency virus: a neurotropic lentivirus. J Acquir Immune Defic Svndr 1990;3: 658-68.
7. Yamamoto JK, Sparger E, Ho EW, et al. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am J Vet Res 1988;49:1246-58.
8. Gunn-Moore DA, Pearson GR, Harbour DA, Whiting CV. Encephalitis associated with giant cells in a cat with naturally occurring feline immunodeficiency virus infection demonstrated by in situ hybridization. Vet Pathol 1996;33:699-703.
9. Prospéro-García O, Herold N, Phillips TR, Elder JH, Bloom FE, Henriksen SJ. Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc Natl Acad Sci USA 1994;91: 12947-51.
10. Podell M, Oglesbee M, Mathes L, Krakowka S, Olmstead R, Lafrado L. AIDS-associated encephalopathy with experimental feline immunodeficiency virus infection. J Acquir immune Defic Syndr 1993;6:758-71.
11. Lafrado LJ, Podell M, Krakowka S, Hayes KA, Hanlon MA, Mathes LE. AIDS research reviews. FIV: a model for retrovirus-induced pathogenesis. New York: Marcel Dekker, 1993:115-50.
12. Pedersen NC. Animal models in AIDS. Feline immunodeficiency virus infection. New York: Elsevier. 1990:165-83.
13. Janssen RS, Cornblath DR, Epstein LG, Foa RP, McArthur JC, Price RW. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus type 1 (HIV-1) infection. Neurology 1991;41:778-85.
14. Sahakian BJ, Elliott R, Low N, Mehta M, Clark RT, Pozniak AL. Neuropsychological deficits in tests of executive function in asymptomatic and symptomatic HIV-1 seropositive men. Psychol Med 1995;25:1233-46.
15. Bloom FE, Rausch DM. HIV in the brain: pathology and neurobehavioral consequences. J Neurovirol 1997;3:102-9.
16. Chadwick EG, Yogev R. Pediatric AIDS. Pediatr Clin North Am 1995;42:969-92.
17. Atwood WJ, Berger JR, Kaderman R, Tornatore CS, Major EO. Human immunodeficiency virus type 1 infection of the brain. Clin Microbiol Rev 1993;6:339-66.
18. Power C, Johnson RT. HIV-1 associated dementia: clinical features and pathogenesis. Can J Neurol Sci 1995;22:92-100.
19. Holtzman DM, Kaku DA, So YT. New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases. Am J Med 1989;87:173-7.
20. Wong MC, Suite NDA, Labar DR. Seizures in human immunodeficiency virus infection. Arch Neurol 1990;47:640-2.
21. Labar DR. Recent advances in epilepsy. Seizures and HIV infection. Edinburgh: Churchill Livingstone, 1992:119-26.
22. Kapoor R, Griffin G, Barrett G, Fowler CJ. Myoclonic epilepsy in an HIV positive patient: neurophysiological findings. Electroencephalgr Clin Neurophysiol 1993;78:80-4.
23. Mintz M. Clinical comparison of adult and pediatric NeuroAIDS. Adv Neuroimmunol 1994;4:207-21.
24. Kozlowski PB, Brudkowska J, Kraszpulski M, et al. Microencephaly in children congenitally infected with human immunodeficiency virus - A gross-anatomical morphometric study. Acta Neuropathol 1997;93:136-45.
25. Gelman BB. Diffuse microgliosis associated with cerebral atrophy in the acquired immunodeficiency syndrome. Ann Neurol 1993; 34:65-70.
26. Weis S, Haug H, Budka H. Astroglial changes in the cerebral cortex of AIDS brains: a morphometric and immunohistochemical investigation. Neuropathol App Neurobiol 1993;19:329-35.
27. Everall IP, Luthert PJ, Lantos PL. Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry 1993;56:481-6.
28. Everall IP, Barnes H, Spargo E, Lantos P. Evidence for selective neuronal loss in the putamen in HIV infected patients using spatial analysis. Clin Neuropathol 1993;12:810.
29. Purba JS, Hofman MA, Portegies P, Troost D, Swaab DF. Decreased number of oxytocin neurons in the paraventricular nucleus of the human hypothalamus in AIDS. Brain 1993;116:795-809.
30. Masliah E, Ge N, Achim CL, Hansen LA, Wiley CA. Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol 1992;51:585-93.
31. Shen Y, Specht SM, De Saint Ghislain I, Li R. The hippocampus: a biological model for studying learning and memory. Prog Neurobiol 1994;44:485-96.
32. Oberfield SE, Cowan L, Levine LS, et al. Altered cortisol response and hippocampal atrophy in pediatric HIV disease. J Acquir Immune Defic Syndr 1994;7:57-62.
33. Reyes E, Mohar A, Mallory M, Miller A, Masliah E. Hippocampal involvement associated with human immunodeficiency virus encephalitis in Mexico. Arch Pathol Lab Med 1994;118:1130-4.
34. Luthert PJ, Montgomery MM, Dean AF, Cook RW, Baskerville A, Lantos PL. Hippocampal neuronal atrophy occurs in rhesus macaques following infection with simian immunodeficiency virus. Neuropathol Appl Neurobiol 1995;21:529-34.
35. O'Neil LL, Burkhard MJ, Diehl LJ, Hoover EA. Vertical transmission of feline immunodeficiency virus. AIDS Res Hum Retroviruses 1995;11:171-82.
36. Dreitz MJ, Dow SW, Fiscus SA, Hoover EA. Development of monoclonal antibodies and capture immunoassays for feline immunodeficiency virus. Am J Vet Res 1995;56:764-8.
37. Cronin J, Obenaus A, Houser CR, Dudek FE. Electrophysiology of dentate granule cells after kainate-induced synaptic reorganization of the mossy fibers. Brain Res 1992;573:305-10.
38. Danscher G. Histochemical demonstration of heavy metals: a revised version of the sulphide silver method suitable for both light and electron microscopy. Histochemistry 1981;71:1-16.
39. Bendinelli M, Pistello M, Lombardi S, et al. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev 1995;8:87-112.
40. Steward O. Lesion-induced synapse reorganization in the hippocampus of cats: sprouting of entorhinal, commissural/ associational, and mossy fiber projections after unilateral entorhinal cortex lesions, with comments on the normal organization of these pathways. Hippocampus 1992;2:247-68.
41. Purpura DP, Housepian EM. Morphological and physiological properties of chronically isolated immature neocortex. Exp Neurol 1961;4:377-401.
42. Salin P, Tseng GF, Hoffman S, Parada I, Prince DA. Axonal sprouting in layer V pyramidal neurons of chronically injured cerebral cortex. J Neurosci 1995;15:8234-45.
43. Mitchell J, Gatherer M, Sundstrom LE. Aberrant Timm-stained fibres in the dentate gyrus following tetanus toxin-induced seizures in the rat. Neuropathol App Neurobiol 1996;22:129-35.
44. Perez Y, Morin F, Beaulieu C, Lacaille JC. Axonal sprouting of CA1 pyramidal cells in hyperexcitable hippocampal slices of kainate-treated rats. Eur J Neurosci 1996;8:736-48.
45. Meier CL, Dudek FE. Spontaneous and stimulation-induced synchronized burst afterdischarges in the isolated CA1 of kainate-treated rats. J Neurophysiol 1996;76:2231-9.
46. Sutula T, Cascino G, Cavazos J, Parada I, Ramirez L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 1989;26:321-30.
47. Cronin J, Dudek FE. Chronic seizures and collateral sprouting of dentate mossy fibers after kainic acid treatment in rats. Brain Res 1988;474:181-4.
48. Tauck DL, Nadler JV. Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. J Neurosci 1985;5:1016-22.
49. Sloviter RS. Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: "dormant basket cell" hypothesis and its possible relevance to temporal lobe epilepsy. Hippocampus 1991;1:41-66.
50. Buhl EH, Otis TS, Mody I. Zinc-induced collapse of augmented inhibition by GABA in a temporal lobe epilepsy model. Science 1996;271:369-73.
51. Wuarin J-P, Dudek FE. Electrographic seizures and new recurrent excitatory circuits in the dentate gyrus of hippocampal slices from kainate-treated epileptic rats. J Neurosci 1996; 16:4438-48.
52. Pedersen NC, Yamamoto JK, Ishida T, Hansen H. Feline immunodeficiency virus infection. Vet Immunol Immunopathol 1989;21: 111-29.
53. Oliver JE Jr, Lorenz MD. Handbook of veterinary neurology: seizures and narcolepsy, 2nd ed. Philadelphia: WB Saunders, 1993: 296-313.
54. Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 1995;38:563-70.
55. Hasenkrug KJ, Robertson SJ, Portis J, McAtee F, Nishio J, Chesebro B. Two separate envelope regions influence induction of brain disease by a polytropic murine retrovirus (FMCF98). J Virol 1996;70:4825-8.
56. Mitchell TW, Rojko JL, Hartke JR, Mihajlov AR, Kasameyer GA, Gasper PW, Whalen LR. FeLV envelope protein (gp70) variable region 5 causes alterations in calcium homeostasis and toxicity of neurons. J Acquir Immune Defic Svndr Hum Retrovirol 1997;14: 307-20.
57. Prospéro-García O, Herold N, Waters AK, Phillips TR, Elder JH, Henriksen SJ. Intraventricular administration of a FIV-envelope protein induces sleep architecture changes in rats. Brain Res 1994; 659:254-8.
58. Lipton SA. HIV-related neuronal injury: potential therapeutic intervention with calcium channel antagonists and NMDA antagonists. Mol Neurobiol 1994;8:181-96.
59. Glowa JR, Panlilio LV, Brenneman DE, Gozes I, Fridkin M, Hill JM. Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Res 1992;570:49-53.
60. Hill JM, Mervis RF, Avidor R, Moody TW, Brenneman DE. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res 1993;603:222-33.
61. Opp MR, Rady PL, Hughes TK Jr, Cadet P, Tyring SK, Smith EM. Human immunodeficiency virus envelope glycoprotein 120 alters sleep and induces cytokine mRNA expression in rats. Am J Physiol 1996;270:R963-70.
62. Lipton SA. HIV, AIDS, and the brain. Laboratory basis of novel therapeutic strategies to prevent HIV-related neuronal injury. New York: Raven Press, 1994:183-202.
63. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR, Pert CB. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 1988;335:639-12.
64. i homeostasis and induce neurotoxicity in human embryonic neurons. Eur J Neurosci 1995;7: 2285-93.
65. Meucci O, Miller RJ. gp120-Induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-β1. J Neurosci 1996;16:4080-8.
66. Brenneman DE, McCune SK, Mervis RF, Hill JM. gp120 as an etiologic agent for neuroAIDS: neurotoxicity and model systems. Adv Neuroimmunol 1994;4:157-65.
67. Benos DJ, Hahn BH, Bubien JK, et al. Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. Proc Natl Acad Sci USA 1994;91:494-8.
68. Giulian D, Yu J, Li X, et al. Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J Neurosci 1996;16:3139-53.
69. Lipton SA. Models of neuronal injury in AIDS: another role for the NMDA receptor. Trends Neurosci 1992;15:75-9.
70. Barks JDE, Liu XH, Sun R, Silverstein FS. gp120, A human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats. Neuroscience 1997;76:397-409.
71. Aggoun-Zouaoui D, Charriaut-Marlangue C, Rivera S, Jorquera I, Ben-Ari Y, Represa A. The HIV-1 envelope protein GP120 induces neuronal apoptosis in hippocampal slices. Neuroreport 1996;7:433-6.
72. Nadler JV, Perry BW, Cotman CW. Selective reinnervation of hippocampal area CA1 and the fascia dentata after destruction of CA3-CA4 afferents with kainic acid. Brain Res 1980;182:1-9.
73. Cavazos JE, Sutula TP. Progressive neuronal loss induced by kindling: a possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis. Brain Res 1990;527:1-6.
74. Wiznia AA, Lambert G, Pavlakis S. Pediatric HIV infection. Med Clin North Am 1996;80:1309-36.
75. Mizrachi Y, Rodriguez I, Sweetnam PM, Rubinstein A, Volsky DJ. HIV type 1 infection of human cortical neuronal cells: enhancement by select neuronal growth factors. AIDS Res Hum Retroviruses 1994;10:1593-6.